Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014395 |
---|---|
Receipt number | R000016636 |
Scientific Title | An open label, single arm, dose escalation phase 1 trial of PRI-724 in patients with HCV-induced cirrhosis |
Date of disclosure of the study information | 2014/07/01 |
Last modified on | 2022/07/04 18:13:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/06/27 10:14:07 | ||
2 | Update | 2014/07/01 14:04:47 | Institute Institute |
|
3 | Update | 2014/08/15 15:56:46 | Recruitment status |
|
4 | Update | 2014/11/11 10:16:11 | Name of person sending information Name of person sending information |
|
5 | Update | 2016/01/14 09:16:15 | Organization Organization Category of Funding Organization |
|
6 | Update | 2016/11/17 16:30:47 | Name of primary person or sponsor Department Organization Category of Funding Organization Co-sponsor Co-sponsor |
|
7 | Update | 2016/11/17 16:31:42 | Recruitment status |
|
8 | Update | 2017/04/18 11:39:19 | Recruitment status Date trial data considered complete |
|
9 | Update | 2022/06/15 16:07:03 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Address Organization1 Address1 Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 IND to MHLW |
|
10 | Update | 2022/06/15 16:10:53 | Publication of results Number of participants that the trial has enrolled |
|
11 | Update | 2022/06/15 16:18:00 | Date of IRB Last follow-up date Date analysis concluded |
|
12 | Update | 2022/06/15 16:47:16 | Organization1 Email1 |
|
13 | Update | 2022/07/04 17:50:17 | Email Email1 |
|
14 | Update | 2022/07/04 17:57:19 | Interventions/Control_1 Interventions/Control_1 |
|
15 | Update | 2022/07/04 18:13:41 | Recruitment status |